LAMA2-related muscular dystrophy: genes and variants
Explore variant evidence for LAMA2-related muscular dystrophy across 1 analyzed protein (LAMA2). Linked ClinVar records include 11 pathogenic or likely pathogenic variants, 893 variants of uncertain significance and 208 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to LAMA2-related muscular dystrophy
LAMA2: Laminin subunit alpha-2
It links cells to surrounding extracellular matrix through dystroglycan and integrins. Biallelic loss-of-function variants cause LAMA2-related muscular dystrophy, ranging from severe congenital disease to later-onset limb-girdle weakness.
11 ClinVar pathogenic / likely pathogenic and 1,101 uncertain variants in LAMA2 have source records linked to LAMA2-related muscular dystrophy. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to LAMA2-related muscular dystrophy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LAMA2 C1079R | 1079 | Laminin EGF-like 12 | Pathogenic / likely pathogenic (★★) |
| LAMA2 H2848Q | 2848 | Laminin G-like 4 | Pathogenic / likely pathogenic (★★) |
| LAMA2 R1508K | 1508 | Laminin EGF-like 16 | Pathogenic / likely pathogenic (★★) |
| LAMA2 H2627Q | 2627 | Laminin G-like 3 | Pathogenic / likely pathogenic (★★) |
| LAMA2 C393G | 393 | Laminin EGF-like 2 | Pathogenic / likely pathogenic (★) |
| LAMA2 C442W | 442 | Laminin EGF-like 3 | Pathogenic / likely pathogenic (★) |
| LAMA2 R1508T | 1508 | Laminin EGF-like 16 | Pathogenic / likely pathogenic (★) |
| LAMA2 G2889E | 2889 | Laminin G-like 4 | Pathogenic / likely pathogenic (★) |
| LAMA2 C2909R | 2909 | Laminin G-like 4 | Pathogenic / likely pathogenic (★) |
| LAMA2 D267N | 267 | Laminin N-terminal | Pathogenic / likely pathogenic (★) |
| LAMA2 T821P | 821 | Laminin EGF-like 7 | Pathogenic / likely pathogenic (★) |
Which prediction tools work for LAMA2-related muscular dystrophy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 90 out of 100
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- VARITY: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 84 out of 100
- SIFT: 80 out of 100
- CADD: 78 out of 100
- PolyPhen-2: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 76 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 73 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 71 out of 100
- phastCons: 62 out of 100
- Pangolin: 30 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Merosin deficient congenital muscular dystrophy also has ClinVar records linked to LAMA2 variants; they fall mostly in different places as the LAMA2-related muscular dystrophy variants (9 pathogenic / likely pathogenic).
- Limb-girdle muscular dystrophy also has ClinVar records linked to LAMA2 variants; they fall mostly in different places as the LAMA2-related muscular dystrophy variants (4 pathogenic / likely pathogenic).
Diseases related to LAMA2-related muscular dystrophy
- Limb-girdle muscular dystrophy, also linked to LAMA2
- Muscular dystrophy due to LMNA mutation, also linked to LAMA2
- Muscular dystrophy, also linked to LAMA2
- Merosin deficient congenital muscular dystrophy, also linked to LAMA2
Frequently asked questions
Which genes have records linked to LAMA2-related muscular dystrophy?
This view contains 1 analyzed proteins: LAMA2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 11 pathogenic or likely pathogenic variants, 893 variants of uncertain significance and 208 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,204 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center